NanoVibronix, Inc. (Nasdaq: NAOV) Takes Center Stage on Approx 37% Early Move

Market Crux Announces New Profile for This Morning! NanoVibronix, Inc. (Nasdaq: NAOV) is #1 on Our Watchlist for This Morning!  Here’s Why… Recent Market Recognition: NanoVibronix, Inc. (Nasdaq: NAOV) moved approximately 28% in the past week, from $.4575 on 10/4 to $.5885 on 10/11. Extremely Low Float: With only 2.76M shares available, its low float could lead to significant price swings, especially if demand shifts. Bullish Signals: On Friday, (NAOV) triggered 15 Bullish Signals on TradingView's 5-minute time-frame, potentially indicating the start of bullish momentum. Under the Radar: With a market cap below $1.7M, (NAOV) appears to be flying under Wall Street’s radar, suggesting a higher growth potential compared to larger companies. Strategic Partnership: NanoVibronix, Inc. (Nasdaq: NAOV) is working towards expanding its UroShield product in Europe through a potential partnership with APOGEPHA Arzneimittel GmbH, which could boost distribution and awareness. Take a Look at NanoVibronix, Inc. (Nasdaq: NAOV) Before the Bell Rings Tomorrow Morning! October 14, 2024 Dear Reader, Have you pulled up NanoVibronix, Inc. (Nasdaq: NAOV) yet?  NanoVibronix, Inc. (Nasdaq: NAOV) just reached $.8033 in the pre-market, marking an approximate 37% move from Friday’s $.585 close. Consider adding NanoVibronix, Inc. (Nasdaq: NAOV) to watch your list this morning before it's too late. After our recent Nasdaq alert saw an approximate move of 189% in just a few days, it's time to shift our focus to NanoVibronix, Inc. (Nasdaq: NAOV). Like that previous profile, NanoVibronix, Inc. (Nasdaq: NAOV) also has an extremely low float, with only 2.76Mn shares available, according to Yahoo. With such a low float, even small changes in demand could lead to significant swings. In the last week, NanoVibronix, Inc. (Nasdaq: NAOV) has moved approximately 28% from $.4575 on 10/4 to reaching $.5885 on Friday 10/11, according to Barchart. Not to mention, with a market cap below $1.7M, NanoVibronix, Inc. (Nasdaq: NAOV) seems to be flying under Wall Street’s radar, suggesting a higher potential for growth compared to mid or large-caps. But this is where it gets interesting… Late in the Friday afternoon session, NanoVibronix, Inc. (Nasdaq: NAOV) triggered 15 Bullish Signals on TradingView’s technical analysis tool using the 5 minute time-frame, including the “Momentum” indicator.  Keep reading to see why you should consider adding NanoVibronix, Inc. (Nasdaq: NAOV) to your Monday morning watchlist… NanoVibronix, Inc. (NASDAQ: NAOV) is a medical device company based in Tyler, Texas, with research and development operations in Nesher, Israel. The company focuses on developing medical devices using its patented low-intensity surface acoustic wave (SAW) technology.  This proprietary technology generates low-frequency ultrasound waves that can be used for various medical applications, including the disruption of biofilms and bacterial colonization, as well as pain relief.  The devices are designed to be used at home, without the need for continuous medical supervision. NanoVibronix’s key products include PainShield® and UroShield®, both portable devices suitable for use in a home or care setting. Recent Development: UroShield’s Expansion in Europe NanoVibronix, Inc. (NASDAQ: NAOV) recently announced the signing of a non-binding term sheet for a license and supply agreement with APOGEPHA Arzneimittel GmbH, a German pharmaceutical company specializing in urology. If the agreement is finalized, APOGEPHA will distribute UroShield® across Europe.  This partnership could leverage APOGEPHA's extensive sales and marketing resources to promote UroShield in Germany, according to Brian Murphy, CEO of NanoVibronix. Dr. Dirk Pamperin, Chairman of APOGEPHA, commented that after evaluating UroShield, they believe the device can significantly help patients with long-term catheters by reducing catheter-associated urinary tract infections (CAUTI). UroShield® uses ultrasound technology to prevent bacterial colonization and biofilm on urinary catheters, increasing antibiotic effectiveness and reducing the discomfort and pain associated with catheter use. This potential collaboration represents an important step for NanoVibronix, Inc. (NASDAQ: NAOV) in expanding the reach of UroShield in the European market, particularly in Germany. 5 reasons to consider adding NanoVibronix, Inc. (NASDAQ: NAOV) to the top of Monday morning’s watchlist…  1. Recent Market Recognition: NanoVibronix, Inc. (Nasdaq: NAOV) has shown strong movement in the past week, moving approximately 28%, from $.4575 on 10/4 to $0.5885 on 10/11.  2. Extremely Low Float: With only 2.76Mn shares available, according to Yahoo, NanoVibronix, Inc. (Nasdaq: NAOV)’s low float has the potential to lead to significant swings, especially if demand begins to shift.  3. Bullish Signals: Late in Friday’s session, NanoVibronix, Inc. (Nasdaq: NAOV) triggered 15 Bullish Signals on TradingView’s analysis tool using the 5-minute time frame. This could indicate the beginning for bullish momentum.  4. Under the Radar: With a market cap below $1.7M, NanoVibronix, Inc. (Nasdaq: NAOV) appears to be flying under Wall Street's radar, until now. Low market cap companies have a higher potential for growth compared to mid or large-caps. 5. Strategic Partnership: NanoVibronix, Inc. (Nasdaq: NAOV) has taken a significant step towards expanding its UroShield product in Europe through a potential partnership with APOGEPHA Arzneimittel GmbH, a German pharmaceutical company. This collaboration could open new avenues for distribution, driving product awareness and adoption in the European market. NanoVibronix, Inc. (Nasdaq: NAOV) has experienced an approximate 28% move over the past week, which could be the beginning of further shifts. With a low float of just 2.76Mn shares, there’s the potential for significant swings if demand changes. On Friday, (NAOV) triggered 15 Bullish Signals, showing the potential for continued momentum.  Additionally, with a market cap under $1.7M, NanoVibronix, Inc. (Nasdaq: NAOV) remains under the radar, but its recent steps toward expanding UroShield in Europe could drive future growth and greater visibility.  Consider adding NanoVibronix, Inc. (Nasdaq: NAOV) #1 to this morning’s watchlist. Sincerely, Gary Silver Managing Editor, MarketCrux MarketCrux.com (“MarketCrux” or “MC” ) is owned by Headline Media LLC, a multi member limited liability company. Data is provided from third-party sources and MarketCrux is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MC brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in.vest.ment advice, are not in.vest.ment advisors, and any profiles we mention are not suitable for all in.vest.ors. The owners of Headline Media LLC own and operate marketcrux . com (“MC”). From time to time, MC will publicly disseminate information about a company via website, email, SMS and other points of media. Please see important disclosure information here: marketcrux.com/disclaimer/ We have not been compensated for October 13-14, 2024’s profile on (NAOV:US). Neither Headline Media or its members owns shares of (NAOV:US).

Headline Media | 7901 4th Street N Suite 300 | St. Petersburg, FL 33702 US Unsubscribe | Update Profile | Constant Contact Data Notice